Skip to main content
Shedir Pharma Group logo

Shedir Pharma Group — Investor Relations & Filings

Ticker · SHE ISIN · IT0005379620 LEI · 81560092B300849E9017 XMIL Manufacturing
Open in API
Filings indexed 124 across all filing types
Latest filing 2023-06-12 Transaction in Own Shar…
Country IT Italy
Listing XMIL SHE

About Shedir Pharma Group

https://www.shedirpharmagroup.com

Shedir Pharma Group specializes in the research, development, formulation, and commercialization of health and wellness products. The company's portfolio encompasses nutraceuticals, dermocosmetics, medical devices, and pharmaceuticals. A key focus is on innovation, resulting in the creation of unique and patented product formulations that cover approximately 15 therapeutic areas. The group operates through specialized subsidiaries that manage the entire product lifecycle, from initial research and intellectual property to marketing and distribution. Products are offered in various forms, such as capsules, tablets, powders, liquids, and gels, targeting professionals in the medical and pharmaceutical sectors.

Recent filings

Filing Released Lang Actions
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Transaction in Own Shares Classification · 99% confidence The document is an official communication from Shedir Pharma Group S.p.A. titled 'AGGIORNAMENTO SULL'ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE' (Update on the Execution of the Own Share Purchase Program). It details the number of shares purchased, the price, and the total consideration for the period between June 5th and June 9th, 2023. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS.
2023-06-12 Italian
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Transaction in Own Shares Classification · 100% confidence The document is an official communication (Informazione Regolamentata) from Shedir Pharma Group dated June 5, 2023. The subject ('Oggetto') is 'AGGIORNAMENTO SULL'ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE' (Update on the Execution of the Own Share Purchase Program). The text details the number of shares bought back, the price, and the total consideration during a specific period (May 29 to June 02). This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing code is POS.
2023-06-05 Italian
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Transaction in Own Shares Classification · 100% confidence The document is an official communication from Shedir Pharma Group S.p.A. titled "AGGIORNAMENTO SULL'ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE" (Update on the Execution of the Own Share Purchase Program). It details the number of shares purchased, the price, and the total consideration for the period between May 22 and May 26, 2023. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. The code for this is POS. Although it is a press release format, the core subject matter is the share repurchase program, making POS more specific than a general Regulatory Filing (RNS) or Report Publication Announcement (RPA).
2023-05-29 Italian
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Transaction in Own Shares Classification · 100% confidence The document is an official communication from Shedir Pharma Group S.p.A. titled "AGGIORNAMENTO SULL'ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE" (Update on the Execution of the Own Share Purchase Program). It details the number of shares bought back between May 15 and May 19, 2023, including daily transaction tables. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory filing (indicated by the 'Informazione Regolamentata' header), the specific nature of the content points precisely to the POS code rather than the general RNS fallback.
2023-05-22 Italian
AGGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Transaction in Own Shares Classification · 100% confidence The document is an official communication (Informazione Regolamentata) from Shedir Pharma Group dated May 15, 2023. The subject ('Oggetto') is 'AGGIORNAMENTO SULL'ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE' (Update on the execution of the own share purchase program). The text details the number of shares bought back between May 8 and May 12, 2023, including aggregated and detailed transaction tables. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory filing (RNS), the specific nature of the content points strongly to POS, which is a more precise classification than the general RNS fallback.
2023-05-15 Italian
GGIORNAMENTO SULL’ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI PROPRIE
Transaction in Own Shares Classification · 99% confidence The document is an official communication (Informazione Regolamentata) from Shedir Pharma Group S.p.A. dated May 2, 2023. The subject ('Oggetto') is 'PROPRIE AGGIORNAMENTO SULL'ESECUZIONE DEL PROGRAMMA DI ACQUISTO AZIONI' (Update on the execution of the share buyback program). The text details the number of shares purchased, the price, and the total consideration for the period between April 24 and April 28, 2023. This activity—the company buying back its own shares—directly corresponds to the definition of 'Transaction in Own Shares'. Therefore, the appropriate filing code is POS.
2023-05-02 Italian

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.